UK Variant Of Coronavirus May Be Harder To Diagnose With Many Current Tests: FDA
Executive Summary
The agency is cautioning that current tests may give false negative results for patients with genetic mutations of SARS-CoV-2, making it harder to control the spread of the pandemic.
You may also be interested in...
Gritstone Jumps Into COVID-19 Vaccine Race, Eyeing Mutant Strains
The company is developing a vaccine with both adenoviral and mRNA technology that could potentially overcome resistance mutations on the SARS-CoV-2 spike protein.
FDA Commissioner Hahn To Seek Public Health Leadership Post To Work On COVID-19 Issues Next
Outgoing US FDA chief Stephen Hahn has signaled that he’ll seek a posting in public health, where he can increase equity and help in the fight against COVID-19.
FDA Warns Of False Negatives With Curative’s COVID-19 Test
If not used properly the test can mislead some patients that they do not have the coronavirus. The US FDA says health care providers should consider using another test if patients get a negative result.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: